$4.84
+0.42 (+9.50%)
Open$4.43
Previous Close$4.42
Day High$4.88
Day Low$4.43
52W High$35.71
52W Low$23.31
Volume—
Avg Volume346.3K
Market Cap101.27M
P/E Ratio—
EPS$-0.15
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+661.4% upside
Current
$4.84
$4.84
Target
$36.85
$36.85
$27.29
$36.85 avg
$45.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.48M | 20.04M | 21.53M |
| Net Income | -5,165,355 | -3,853,498 | -4,413,133 |
| Profit Margin | -24.1% | -19.2% | -20.5% |
| EBITDA | -6,655,427 | -5,995,002 | -5,792,790 |
| Free Cash Flow | -3,535,951 | -2,421,928 | -4,008,931 |
| Rev Growth | -8.7% | +0.8% | +4.3% |
| Debt/Equity | 0.24 | 0.25 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |